Skip to main content

Gliga , Otilia

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Gliga , Otilia

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Projects

Biomarcadores neuroinflamatorios en pacientes con migraña: prueba de concepto para el diagnóstico molecular de la enfermedad

IP: Marta Vila Pueyo
Collaborators: Laila Asskour, Patricia Pozo Rosich, Victor José Gallardo Lopez, Otilia Gliga
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 24990
Reference: FERP-2023-MVP
Duration: 17/01/2024 - 16/01/2026

X

IP: Patricia Pozo Rosich
Collaborators: Otilia Gliga, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 89900
Reference: FI23/00149
Duration: 01/01/2024 - 31/12/2027

Related news

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

The study, conducted in more than 770 people, concludes that atogepant reduces the frequency of migraine attacks and the need to take medication.

Related professionals

Maria Antonia Ramon Belmonte

Maria Antonia Ramon Belmonte

Senior researcher
Pneumology
Read more
Andres Francisco Pacheco Reyes

Andres Francisco Pacheco Reyes

Shock, Organ Dysfunction and Resuscitation
Read more
Ana  Román Mora

Ana Román Mora

Secretary
Communication Unit
Communication Directorate
Read more
Rafael Castilla Gomez

Rafael Castilla Gomez

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.